A Study to Evaluate Non-significant Risk Operation Magnetic Resonance Imaging for MRI Guided Ablation
Start Date
8/30/2021
Completion Date
12/1/2027
Summary
The result of these studies will be used to improve patient care through assessment of new technology to determine whether it is beneficial (i.e. improving data acquisition speed or image quality) during iMRI procedures.
Detailed Description
This proposal includes evaluation of advanced MR imaging methods in the iMRI environment and will operate within the NSR guidelines for data acquisition established by the FDA/CDRH. The significant testing by vendor and Mayo staff prior to in vivo use, assure the safety of these studies and overall system stability. The result of these studies will be used to improve patient care through assessment of new technology to determine whether it is beneficial (i.e. improving data acquisition speed or image quality) during iMRI procedures.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Magnetic Resonance Imaging (MRI)
Conditions
Locations
Mayo Clinic in Rochester
Rochester, Minnesota 55905
United States